Antimicrobial Agents and Chemotherapy · 1999 · 94 citations · 29 references
MedicineInfectious DiseasesPharmacologyInflammationInnate ImmunityNeuroimmunologyAntibacterial PharmacologyBlood-brain Barrier PharmacologyCentral Nervous System InfectionsInflammation In Infectious DiseaseNeuroinflammationNeuroprotectionBacterial Meningitis TreatmentBlood-brain Barrier PermeabilityBlood-tissue Barrier PermeabilityCytokine-mediated Barrier InjuryEscherichia ColiInflammatory Blood-brain Barrier InjuryNeutrophilic InfiltratesTissue Infiltration By Inflammatory Cells
The effect of a water-soluble malonic acid derivative of carboxyfullerence (C60) against Escherichia coli-induced meningitis was tested. C60 can protect the mice from E. coli-induced death in a dose-dependent manner. C60 administered intraperitoneally as late as 9 h after E. coli injection was still protective. The C60-treated mice had less tumor necrosis factor alpha and interleukin-1beta production by staining of brain tissue compared to the levels of production for nontreated mice. The E. coli-induced increases in blood-brain barrier permeability and inflammatory neutrophilic infiltration were also inhibited. These data suggest that C60 is a potentially therapeutic agent for bacterial meningitis.
29
Solid C60: a new form of carbon
Wolfgang Krätschmer, Lowell D. Lamb, K. Fostiropoulos et al. · Nature · 1990 · 7.6K citations
Astrocytes induce blood–brain barrier properties in endothelial cells
Robert C. Janzer, Martin Raff · Nature · 1987 · 1.6K citations
Medicine, Cell Biology, Neuroscience +14
Radical Reactions of C <sub>60</sub>
Paul J. Krusic, E. Wasserman, Petra N. Keizer et al. · Science · 1991 · 912 citations
Carboxyfullerenes as neuroprotective agents
Laura L. Dugan, Dorothy M. Turetsky, Cheng Du et al. · Proceedings of the National Academy of Sciences · 1997 · 745 citations
Medicine, Neuroscience, Pharmacology +17